הידרוקסיקרבמיד
הערות שוליים

1 2 3 4 5 6 7 8 9  "Hydroxyurea". The American Society of Health-System Pharmacists. נבדק ב-8 בדצמבר 2016. {{cite web}}:  (עזרה)
↑  "Hydrea 500 mg Hard Capsules – Summary of Product Characteristics (SPC) – (eMC)". www.medicines.org.uk. אורכב מ-המקור ב-20 בדצמבר 2016. נבדק ב-14 בדצמבר 2016. {{cite web}}:  (עזרה)
↑  World Health Organization, [https://apps.who.int/iris/rest/bitstreams/1237479/retrieve World Health Organization
Model List of Essential Medicines
21st List
2019], ‏2019
↑  "Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia". N. Engl. J. Med. 353 (1): 33–45. ביולי 2005. doi:10.1056/NEJMoa043800. PMID 16000354. {{cite journal}}:  (עזרה)
↑  "Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease". Ann. Intern. Med. 148 (12): 939–55. ביוני 2008. doi:10.7326/0003-4819-148-12-200806170-00221. PMC 3256736. PMID 18458272. {{cite journal}}:  (עזרה)
↑  "Hydroxyurea as an alternative therapy for psoriasis". Indian J Dermatol Venereol Leprol. 2004. pp. 13–7. PMID 17642550. אורכב מ-המקור ב-2009-07-03.
↑  Escribano, L.; Álvarez-Twose, I. N.; Sánchez-Muñoz, L.; Garcia-Montero, A.; Núñez, R.; Almeida, J.; Jara-Acevedo, M.; Teodósio, C.;  et al. (2009). "Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients". Journal of Allergy and Clinical Immunology. 124 (3): 514–521. doi:10.1016/j.jaci.2009.05.003. PMID 19541349.
↑  Dalziel, K.; Round, A.; Stein, K.; Garside, R.; Price, A. (2004). "Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: A systematic review and economic analysis". Health Technology Assessment. 8 (28): iii, ii1–120. doi:10.3310/hta8280. PMID 15245690free{{cite journal}}:  תחזוקה - ציטוט: postscript (link)
↑  Liebelt, E.; Balk, S.; Faber, W.; Fisher, J.; Hughes, C.; Lanzkron, S.; Lewis, K.; Marchetti, F.; Mehendale, H. (2007). "NTP-CERHR expert panel report on the reproductive and developmental toxicity of hydroxyurea". Birth Defects Research, Part B. 80 (4): 259–366. doi:10.1002/bdrb.20123. PMID 17712860.
↑  The Gale encyclopedia of cancer : a guide to cancer and its treatments, Detroit : Thomson/Gale, 2005, עמ' 514-516, ISBN 978-1-4144-0362-5
↑  "HYDREA" (PDF). Accessdata.fda.gov. US Food and Drug Administration.
1 2  Platt OS (2008). "Hydroxyurea for the treatment of sickle cell anemia". N. Engl. J. Med. 358 (13): 1362–9. doi:10.1056/NEJMct0708272. PMID 18367739.
↑  Orah S. Platt, Hydroxyurea for the treatment of sickle cell anemia, The New England Journal of Medicine 358, 2008-03-27, עמ' 1362–1369 doi: 10.1056/NEJMct0708272
↑  "Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase". J Clin Invest. 111 (2): 231–9. 2003. doi:10.1172/JCI16672. PMC 151872. PMID 12531879.
↑  Kettani, T; Gulbis, B; Ferster, A; Kumps, A (2009). "Plasma hydroxyurea determined by gas chromatography-mass spectrometry". Journal of Chromatography B. 877 (4): 446–450. doi:10.1016/j.jchromb.2008.12.048. PMID 19144580.
↑  Dresler WFC; Stein R (1869). "Ueber den Hydroxylharnstoff". Justus Liebigs Ann. Chem. pp. 1317–22. doi:10.1002/jlac.18691500212.
↑  Rees C. David (2011). "The rationale for using hydroxycarbamide in the treatment of sickle cell disease". Haematologica. 96 (4): 488–491. doi:10.3324/haematol.2011.041988. PMC 3069221. PMID 21454878.
↑  Graham P.J. (1955). "Synthesis of Ureas". E.I. du Pont de Nemours & Co., Wilmington, DE. US Patent No. 2, 705, 727.
↑  "New Method for Synthesis of Hydroxyurea and Some of its Polymer Supported Derivatives As New Controlled Release Drugs". Journal of Basrah Research. 41 (1). 2016. doi:10.13140/RG.2.1.3607.2720.
↑  "Pharmacology and Biochemistry". PubChem. אורכב מ-המקור ב-2017-05-18.
↑  "Hydroxyurea arrests DNA replication by a mechanism that preserves basal dNTP pools". J. Biol. Chem. בינואר 2004. pp. 223–30. doi:10.1074/jbc.M303952200. PMID 14573610free {{cite web}}:  (עזרה)תחזוקה - ציטוט: postscript (link)
↑  Yarbro JW (1992). "Mechanism of Action". Seminars in Oncology. 19 (3): 1–10. PMID 1641648.
↑  "Pharmacology and Biochemistry". PubChem. אורכב מ-המקור ב-2017-05-18.
הבהרה: המידע בוויקיפדיה נועד להעשרה בלבד ואינו מהווה ייעוץ רפואי.